Identifying menopause in breast cancer patients : considerations and implicationsCLEMONS, Mark; SIMMONS, Christine.Breast cancer research and treatment. 2007, Vol 104, Num 2, pp 115-120, issn 0167-6806, 6 p.Article

Recent developments in bisphosphonates for patients with metastatic breast cancerGAINFORD, Mary C; DRANITSARIS, George; CLEMONS, Mark et al.BMJ. British medical journal (International ed.). 2005, Vol 330, Num 7494, pp 769-773, issn 0959-8146, 5 p.Article

Pharmacotherapy of bone metastases in breast cancer patients - an updateJACOBS, Carmel; SIMOS, Demetrios; ADDISON, Christina et al.Expert opinion on pharmacotherapy. 2014, Vol 15, Num 8, pp 1109-1118, issn 1465-6566, 10 p.Article

Adjuvant bisphosphonate treatment for breast cancer: Why did something so elegant become so complicated?CLEMONS, Mark; RUSSELL, Kent; COSTA, Luis et al.Breast cancer research and treatment. 2012, Vol 134, Num 2, pp 453-457, issn 0167-6806, 5 p.Article

Overcoming endocrine resistance in breast cancer : are signal transduction inhibitors the answer?BEDARD, Philippe L; FREEDMAN, Orit C; HOWELL, Anthony et al.Breast cancer research and treatment. 2008, Vol 108, Num 3, pp 307-317, issn 0167-6806, 11 p.Article

Perspectives on the future of bisphosphonate use in breast cancer patients : IbandronateCLEMONS, Mark; REA, Daniel.Seminars in oncology. 2004, Vol 31, Num 5, pp 87-91, issn 0093-7754, 5 p., SUP10Article

Randomized Feasibility Study of De-escalated (Every 12 wk) Versus Standard (Every 3 to 4 wk) Intravenous Pamidronate in Women With Low-risk Bone Metastases From Breast CancerAMIR, Eitan; FREEDMAN, Orit; CARLSSON, Lindsay et al.American journal of clinical oncology. 2013, Vol 36, Num 5, pp 436-442, issn 0277-3732, 7 p.Article

A Phase 2 Trial Exploring the Effects of High-Dose (10,000 IU/Day) Vitamin D₃ in Breast Cancer Patients With Bone MetastasesAMIR, Eitan; SIMMONS, Christine E; FREEDMAN, Orit C et al.Cancer. 2010, Vol 116, Num 2, pp 284-291, issn 0008-543X, 8 p.Article

Phase I/II Trial of Metronomic Chemotherapy With Daily Dalteparin and Cyclophosphamide, Twice-Weekly Methotrexate, and Daily Prednisone As Therapy for Metastatic Breast Cancer Using Vascular Endothelial Growth Factor and Soluble Vascular Endothelial Growth Factor Receptor Levels As Markers of ResponseNAN SOON WONG; BUCKMAN, Robert A; SUTHERLAND, Donald J. A et al.Journal of clinical oncology. 2010, Vol 28, Num 5, pp 723-730, issn 0732-183X, 8 p.Article

A Phase 2 study of perifosine in advanced or metastatic breast cancerLEIGHL, Natasha B; DENT, Susan; MOORE, Malcolm J et al.Breast cancer research and treatment. 2008, Vol 108, Num 1, pp 87-92, issn 0167-6806, 6 p.Article

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapyCLEMONS, Mark; JOY, Anil A; ABDULNABI, Radhi et al.Breast cancer research and treatment. 2010, Vol 124, Num 1, pp 177-186, issn 0167-6806, 10 p.Article

Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastasesHARRIS, Kristin; CHOW, Edward; YEE, Albert et al.European journal of cancer (1990). 2009, Vol 45, Num 14, pp 2510-2518, issn 0959-8049, 9 p.Article

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163ELLARD, Susan L; CLEMONS, Mark; SAUERBREI, Eric et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4536-4541, issn 0732-183X, 6 p.Article

Pain Outcomes in Patients With Advanced Breast Cancer and Bone Metastases: Results From a Randomized, Double-Blind Study of Denosumab and Zoledronic AcidCLEELAND, Charles S; BODY, Jean-Jacques; LIPTON, Allan et al.Cancer. 2013, Vol 119, Num 4, pp 832-838, issn 0008-543X, 7 p.Article

The symptom appraisal of breast cancer in the context of an intimate relationshipFERGUS, Karen; FITZGERALD, Barbara; GRANEK, Leeat et al.Journal of health psychology. 2011, Vol 16, Num 4, pp 653-666, issn 1359-1053, 14 p.Article

Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone PainBROOM, Reuben; HONGYAN DU; CLEMONS, Mark et al.Journal of pain and symptom management. 2009, Vol 38, Num 2, pp 244-257, issn 0885-3924, 14 p.Article

Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer : A multicenter phase II trialCHIA, Stephen; CLEMONS, Mark; MARTIN, Lee-Ann et al.Journal of clinical oncology. 2006, Vol 24, Num 18, pp 2773-2778, issn 0732-183X, 6 p.Article

Liarozole fumarate (R85246): In the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancerGOSS, Paul E; STRASSER, Kathrin; DE COSTER, Roland et al.Breast cancer research and treatment. 2000, Vol 64, Num 2, pp 177-188, issn 0167-6806Article

Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast CancerAMIR, Eitan; MILLER, Naomi; TANNOCK, Ian F et al.Journal of clinical oncology. 2012, Vol 30, Num 6, pp 587-592, issn 0732-183X, 6 p.Article

Altered Calcium Metabolism in Patients on Long-term Bisphosphonate Therapy for Metastatic Breast CancerSIMMONS, Christine; AMIR, Eitan; DRANITSARIS, George et al.Anticancer research. 2009, Vol 29, Num 7, pp 2707-2711, issn 0250-7005, 5 p.Article

Examination of the mechanisms of osteolysis in patients with metastatic breast cancerTRINKAUS, Mateya; WEI SEONG OOI; AMIR, Ethan et al.Oncology reports. 2009, Vol 21, Num 5, pp 1153-1159, issn 1021-335X, 7 p.Article

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patientsFREEDMAN, Orit; AMIR, Eitan; AHMAD, Imran et al.Breast cancer research and treatment. 2009, Vol 118, Num 2, pp 377-383, issn 0167-6806, 7 p.Article

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and deathRAKOVITCH, Eileen; PIGNOL, Jean-Philippe; CHARTIER, Carole et al.Breast cancer research and treatment. 2005, Vol 90, Num 2, pp 139-148, issn 0167-6806, 10 p.Article